China Shineway Pharmaceutical Group (OTCPK:CSWYY) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
China Shineway Pharmaceutical Group PS Ratio Related Terms
China Shineway Pharmaceutical Group PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Shineway Pharmaceutical Group PS Ratio Chart
For the Drug Manufacturers - Specialty & Generic subindustry, China Shineway Pharmaceutical Group's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Shineway Pharmaceutical Group PS Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, China Shineway Pharmaceutical Group's PS Ratio distribution charts can be found below:
* The bar in red indicates where China Shineway Pharmaceutical Group's PS Ratio falls into.
China Shineway Pharmaceutical Group PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
China Shineway Pharmaceutical Group's Share Price of today is $19.25.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. China Shineway Pharmaceutical Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $11.67.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
China Shineway Pharmaceutical Group (CSWYY) has a PS Ratio of 1.65 as of Jun. 26, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on China Shineway Pharmaceutical Group and its competitors. This is near median its historical median of 1.62. Over the past decade, China Shineway Pharmaceutical Group's PS Ratio has ranged from 0.92 to 6.29. According to the industry distribution chart, China Shineway Pharmaceutical Group ranks #369 out of 953 companies in the Drug Manufacturers industry, placing it in the top 38.7%.
Is China Shineway Pharmaceutical Group's PS Ratio too high?
China Shineway Pharmaceutical Group's current PS Ratio of 1.65 is near median its 10-year median of 1.62. Over the past 10 years, this metric has ranged from a low of 0.92 to a high of 6.29. The Drug Manufacturers industry median PS Ratio is 2.20. China Shineway Pharmaceutical Group's value of 1.65 is 25% below this industry median. Based on the distribution chart, China Shineway Pharmaceutical Group ranks #369 out of 953 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, China Shineway Pharmaceutical Group has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does China Shineway Pharmaceutical Group's PS Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, China Shineway Pharmaceutical Group ranks #369 out of 953 companies for PS Ratio. This puts China Shineway Pharmaceutical Group in the upper half of its industry. The industry median PS Ratio is 2.20. China Shineway Pharmaceutical Group's value of 1.65 is 25% below this benchmark. Historically, China Shineway Pharmaceutical Group's own PS Ratio has ranged from 0.92 to 6.29 over the past decade. While the company's 10-year median is 1.62 vs. the industry median of 2.20, China Shineway Pharmaceutical Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Drug Manufacturers company?
The median PS Ratio among Drug Manufacturers companies is 2.20, based on 953 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Shineway Pharmaceutical Group's current PS Ratio of 1.65 is 25% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on China Shineway Pharmaceutical Group and its competitors. For the Drug Manufacturers industry, the median PS Ratio is 2.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Shineway Pharmaceutical Group's current PS Ratio is 1.65, which is near median its own 10-year median of 1.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Shineway Pharmaceutical Group stock overvalued right now?
China Shineway Pharmaceutical Group (CSWYY) has a current PS Ratio of 1.65. The stock's GF Value™ is $16.85, compared to a current price of $19.25 — trading 14.2% above its estimated fair value. The current PS Ratio is 1.65, which is near median its 10-year median of 1.62 and 25% below the Drug Manufacturers industry median of 2.20. China Shineway Pharmaceutical Group's overall GF Score™ is 92/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For China Shineway Pharmaceutical Group (CSWYY), the current PS Ratio is 1.65 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Shineway Pharmaceutical Group (CSWYY) Overvalued in 2026?
Based on GuruFocus' analysis, China Shineway Pharmaceutical Group stock appears to be overvalued.
The current stock price of $19.25 is trading 14.2% above its estimated GF Value™ of $16.85.
Key valuation signals for CSWYY:
PS Ratio: 1.65 (near median its 10-year median of 1.62)
GF Value™: $16.85 vs. price of $19.25 (14.2% above fair value)
Industry Position: 25% below the Drug Manufacturers median (#369 of 953)
No single metric tells the full story. See the CSWYY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Shineway Pharmaceutical Group Business Description
China Shineway Pharmaceutical Group Ltd is an investment holding company. Along with its subsidiaries, it is engaged in the research, development, manufacturing, and trading of modern Chinese medicines. The company's products comprise injection, soft capsule, granule, traditional Chinese medicine formula granules, and others, of which injections generate maximum revenue for the company. Geographically, the group operates in the People's Republic of China (PRC) and Hong Kong.
92GF Score
Get the complete analysis for CSWYY
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CSWYY has been successfully added to your 
